ELIZABETH HOFF joined Fannin Innovation Studio in August, 2018 as Managing Director. Prior to Fannin, she spent 25 years in Medical Devices focused on commercializing high-tech devices in General, Vascular and Cardiac surgery with Guidant and W. L. Gore. Most recently, she was Vice President and General Manager of the Cardiac Diagnostics business unit in Medtronic’s Cardiac Rhythm and Heart Failure Division. Under her leadership, Medtronic launched the Reveal LinQ device for detecting arrhythmias for syncopal and atrial fibrillation patients. Elizabeth graduated from Rice University in 1987 with a double major in Managerial Studies and Psychology.
IN PUBLIC MEDIA